ID   FKB10_HUMAN             Reviewed;         582 AA.
AC   Q96AY3; Q7Z3R4; Q9H3N3; Q9H6J3; Q9H6N5; Q9UF89;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP10;
DE            Short=PPIase FKBP10;
DE            EC=5.2.1.8;
DE   AltName: Full=65 kDa FK506-binding protein;
DE            Short=65 kDa FKBP;
DE            Short=FKBP-65;
DE   AltName: Full=FK506-binding protein 10;
DE            Short=FKBP-10;
DE   AltName: Full=Immunophilin FKBP65;
DE   AltName: Full=Rotamase;
DE   Flags: Precursor;
GN   Name=FKBP10; Synonyms=FKBP65; ORFNames=PSEC0056;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Rulten S., Kinloch R.A., Robinson C., Gettins L., Kay J.E.;
RT   "The human FK506-binding protein repertoire.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 82-582 (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrial tumor, and Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   GLYCOSYLATION AT ASN-182 AND ASN-407.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-182.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   VARIANT OI11 MET-107--117-LEU DEL.
RX   PubMed=20362275; DOI=10.1016/j.ajhg.2010.02.022;
RA   Alanay Y., Avaygan H., Camacho N., Utine G.E., Boduroglu K., Aktas D.,
RA   Alikasifoglu M., Tuncbilek E., Orhan D., Bakar F.T., Zabel B.,
RA   Superti-Furga A., Bruckner-Tuderman L., Curry C.J., Pyott S.,
RA   Byers P.H., Eyre D.R., Baldridge D., Lee B., Merrill A.E., Davis E.C.,
RA   Cohn D.H., Akarsu N., Krakow D.;
RT   "Mutations in the gene encoding the RER protein FKBP65 cause
RT   autosomal-recessive osteogenesis imperfecta.";
RL   Am. J. Hum. Genet. 86:551-559(2010).
RN   [12]
RP   VARIANT BRKS1 GLN-115, AND INVOLVEMENT IN OI11.
RX   PubMed=20839288; DOI=10.1002/jbmr.250;
RA   Kelley B.P., Malfait F., Bonafe L., Baldridge D., Homan E.,
RA   Symoens S., Willaert A., Elcioglu N., Van Maldergem L.,
RA   Verellen-Dumoulin C., Gillerot Y., Napierala D., Krakow D.,
RA   Beighton P., Superti-Furga A., De Paepe A., Lee B.;
RT   "Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck
RT   syndrome.";
RL   J. Bone Miner. Res. 26:666-672(2011).
RN   [13]
RP   VARIANTS BRKS1 LYS-113; GLN-115 AND LEU-136, AND INVOLVEMENT IN OI11.
RX   PubMed=22949511; DOI=10.1093/hmg/dds371;
RA   Schwarze U., Cundy T., Pyott S.M., Christiansen H.E., Hegde M.R.,
RA   Bank R.A., Pals G., Ankala A., Conneely K., Seaver L., Yandow S.M.,
RA   Raney E., Babovic-Vuksanovic D., Stoler J., Ben-Neriah Z., Segel R.,
RA   Lieberman S., Siderius L., Al-Aqeel A., Hannibal M., Hudgins L.,
RA   McPherson E., Clemens M., Sussman M.D., Steiner R.D., Mahan J.,
RA   Smith R., Anyane-Yeboa K., Wynn J., Chong K., Uster T., Aftimos S.,
RA   Sutton V.R., Davis E.C., Kim L.S., Weis M.A., Eyre D., Byers P.H.;
RT   "Mutations in FKBP10, which result in Bruck syndrome and recessive
RT   forms of osteogenesis imperfecta, inhibit the hydroxylation of
RT   telopeptide lysines in bone collagen.";
RL   Hum. Mol. Genet. 22:1-17(2013).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins during
CC       protein synthesis.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Inhibited by both FK506 and rapamycin, but not
CC       by cyclosporin A. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000255|PROSITE-ProRule:PRU10138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96AY3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96AY3-2; Sequence=VSP_056425, VSP_056426, VSP_056427,
CC                                  VSP_056428;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Glycosylated and phosphorylated. {ECO:0000250}.
CC   -!- DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of
CC       osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility
CC       to fractures after minimal trauma. Disease severity ranges from
CC       very mild forms without fractures to intrauterine fractures and
CC       perinatal lethality. Extraskeletal manifestations, which affect a
CC       variable number of patients, are dentinogenesis imperfecta,
CC       hearing loss, and blue sclerae. OI11 is an autosomal recessive
CC       form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288,
CC       ECO:0000269|PubMed:22949511}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease
CC       characterized by generalized osteopenia, congenital joint
CC       contractures, fragile bones with onset of fractures in infancy or
CC       early childhood, short stature, severe limb deformity, progressive
CC       scoliosis, and pterygia. {ECO:0000269|PubMed:20839288,
CC       ECO:0000269|PubMed:22949511}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15220.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD97695.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Peptidyl-prolyl cis-trans isomerase FKBP10;
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=FKBP10";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF337909; AAM15770.1; -; mRNA.
DR   EMBL; AK025694; BAB15220.1; ALT_INIT; mRNA.
DR   EMBL; AK025874; BAB15266.1; -; mRNA.
DR   EMBL; AB045981; BAB20974.1; -; mRNA.
DR   EMBL; BX537452; CAD97695.1; ALT_INIT; mRNA.
DR   EMBL; AL133116; CAB61418.1; -; mRNA.
DR   EMBL; AC091172; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016467; AAH16467.1; -; mRNA.
DR   CCDS; CCDS11409.1; -. [Q96AY3-1]
DR   PIR; T42709; T42709.
DR   RefSeq; NP_068758.3; NM_021939.3. [Q96AY3-1]
DR   UniGene; Hs.463035; -.
DR   ProteinModelPortal; Q96AY3; -.
DR   SMR; Q96AY3; -.
DR   BioGrid; 121955; 22.
DR   IntAct; Q96AY3; 4.
DR   STRING; 9606.ENSP00000317232; -.
DR   iPTMnet; Q96AY3; -.
DR   PhosphoSitePlus; Q96AY3; -.
DR   SwissPalm; Q96AY3; -.
DR   BioMuta; FKBP10; -.
DR   DMDM; 23396594; -.
DR   EPD; Q96AY3; -.
DR   MaxQB; Q96AY3; -.
DR   PaxDb; Q96AY3; -.
DR   PeptideAtlas; Q96AY3; -.
DR   PRIDE; Q96AY3; -.
DR   TopDownProteomics; Q96AY3-1; -. [Q96AY3-1]
DR   DNASU; 60681; -.
DR   Ensembl; ENST00000321562; ENSP00000317232; ENSG00000141756. [Q96AY3-1]
DR   GeneID; 60681; -.
DR   KEGG; hsa:60681; -.
DR   UCSC; uc002hxv.3; human. [Q96AY3-1]
DR   CTD; 60681; -.
DR   DisGeNET; 60681; -.
DR   GeneCards; FKBP10; -.
DR   HGNC; HGNC:18169; FKBP10.
DR   HPA; HPA051171; -.
DR   HPA; HPA057021; -.
DR   MalaCards; FKBP10; -.
DR   MIM; 259450; phenotype.
DR   MIM; 607063; gene.
DR   MIM; 610968; phenotype.
DR   neXtProt; NX_Q96AY3; -.
DR   OpenTargets; ENSG00000141756; -.
DR   Orphanet; 1149; Arthrogryposis-like syndrome.
DR   Orphanet; 2771; Bruck syndrome.
DR   Orphanet; 216828; Osteogenesis imperfecta type 5.
DR   PharmGKB; PA28152; -.
DR   eggNOG; KOG0549; Eukaryota.
DR   eggNOG; COG0545; LUCA.
DR   GeneTree; ENSGT00530000062784; -.
DR   HOGENOM; HOG000230960; -.
DR   HOVERGEN; HBG051620; -.
DR   InParanoid; Q96AY3; -.
DR   KO; K09575; -.
DR   OrthoDB; EOG091G02W1; -.
DR   PhylomeDB; Q96AY3; -.
DR   TreeFam; TF105296; -.
DR   ChiTaRS; FKBP10; human.
DR   GenomeRNAi; 60681; -.
DR   PRO; PR:Q96AY3; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141756; -.
DR   CleanEx; HS_FKBP10; -.
DR   ExpressionAtlas; Q96AY3; baseline and differential.
DR   Genevisible; Q96AY3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005528; F:FK506 binding; IBA:GO_Central.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IBA:GO_Central.
DR   CDD; cd00051; EFh; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   PANTHER; PTHR10516; PTHR10516; 1.
DR   Pfam; PF13202; EF-hand_5; 2.
DR   Pfam; PF00254; FKBP_C; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Isomerase; Metal-binding;
KW   Osteogenesis imperfecta; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Rotamase; Signal.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    582       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP10.
FT                                /FTId=PRO_0000025517.
FT   DOMAIN       62    150       PPIase FKBP-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      174    262       PPIase FKBP-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      286    374       PPIase FKBP-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      399    486       PPIase FKBP-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      497    532       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      542    577       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     510    521       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     555    566       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       579    582       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    294    294       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    393    393       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   VAR_SEQ       2    177       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056425.
FT   VAR_SEQ     184    212       TLLDGTSFDTSYSKGGTYDTYVGSGWLIK -> SLMDGTLF
FT                                DSSYSRNHTYNTYIGQGYIIP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056426.
FT   VAR_SEQ     219    303       LGMCPGERRKIIIPPFLAYGEKGYGTVIPPQASLVFHVLLI
FT                                DVHNPKDAVQLETLELPPGCVRRAGAGDFMRYHYNGSLMDG
FT                                TLF -> QGACMGERRRITIPPHLAYGENGTDSIGFLQGSA
FT                                PLRPFRSGEGQPSLGREGGYGKTEPAYPQDPAVLGASVSSP
FT                                VKWASHADPQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056427.
FT   VAR_SEQ     304    354       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056428.
FT   VARIANT     107    117       Missing (in OI11).
FT                                /FTId=VAR_063601.
FT   VARIANT     113    113       E -> K (in BRKS1; dbSNP:rs397514674).
FT                                {ECO:0000269|PubMed:22949511}.
FT                                /FTId=VAR_069902.
FT   VARIANT     115    115       R -> Q (in BRKS1; dbSNP:rs387906960).
FT                                {ECO:0000269|PubMed:20839288,
FT                                ECO:0000269|PubMed:22949511}.
FT                                /FTId=VAR_069903.
FT   VARIANT     136    136       P -> L (in BRKS1; dbSNP:rs782653042).
FT                                {ECO:0000269|PubMed:22949511}.
FT                                /FTId=VAR_069904.
FT   VARIANT     197    197       K -> R (in dbSNP:rs34764749).
FT                                /FTId=VAR_050625.
FT   CONFLICT    190    190       S -> F (in Ref. 3; BAB20974).
FT                                {ECO:0000305}.
FT   CONFLICT    456    456       V -> L (in Ref. 4; CAD97695).
FT                                {ECO:0000305}.
SQ   SEQUENCE   582 AA;  64245 MW;  98257459158407C2 CRC64;
     MFPAGPPSHS LLRLPLLQLL LLVVQAVGRG LGRASPAGGP LEDVVIERYH IPRACPREVQ
     MGDFVRYHYN GTFEDGKKFD SSYDRNTLVA IVVGVGRLIT GMDRGLMGMC VNERRRLIVP
     PHLGYGSIGL AGLIPPDATL YFDVVLLDVW NKEDTVQVST LLRPPHCPRM VQDGDFVRYH
     YNGTLLDGTS FDTSYSKGGT YDTYVGSGWL IKGMDQGLLG MCPGERRKII IPPFLAYGEK
     GYGTVIPPQA SLVFHVLLID VHNPKDAVQL ETLELPPGCV RRAGAGDFMR YHYNGSLMDG
     TLFDSSYSRN HTYNTYIGQG YIIPGMDQGL QGACMGERRR ITIPPHLAYG ENGTGDKIPG
     SAVLIFNVHV IDFHNPADVV EIRTLSRPSE TCNETTKLGD FVRYHYNCSL LDGTQLFTSH
     DYGAPQEATL GANKVIEGLD TGLQGMCVGE RRQLIVPPHL AHGESGARGV PGSAVLLFEV
     ELVSREDGLP TGYLFVWHKD PPANLFEDMD LNKDGEVPPE EFSTFIKAQV SEGKGRLMPG
     QDPEKTIGDM FQNQDRNQDG KITVDELKLK SDEDEERVHE EL
//
